Exposure assessment based recommendations to improve nanosafety at nanoliposome production sites

The NANOFOL concept aims at creating nanodevices containing a drug for inflammatory disorder treatment. This paper provides recommendations for nanosafety based on a measurement campaign which aimed at identifying exposure risks with respect to two specific phases of the products lifecycle, that is, production of the device and its waste management. The nanoparticles presence both in air and in liquid phase was studied. While no emissions were detected during the production period, many recommendations have been made, particularly regarding the nanowaste treatment, based on nanosafety guidelines.Eugenia Nogueira (SFRH/BD/81269/2011) holds scholarships from Fundacao para a Ciencia e a Tecnologia (FCT). The authors thank the EC for funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement NMP4-LA-2009-228827 NANOFOL